Conformis Inc. (CFMS)
NASDAQ: CFMS
· Real-Time Price · USD
2.27
0.01 (0.44%)
At close: Sep 01, 2023, 9:57 PM
Conformis Revenue Breakdown
| Period Ending | Dec 31, 2022 | Dec 31, 2021 | Dec 31, 2020 | Dec 31, 2019 |
|---|---|---|---|---|
| Royalty Revenue | 4.22M | 41.54M | 10.22M | 780K |
| Royalty Revenue Growth | -89.83% | +306.44% | +1210.38% | n/a |
Revenue by Geography
| Period Ending | Dec 31, 2022 | Dec 31, 2021 | Dec 31, 2020 | Dec 31, 2019 | Dec 31, 2018 | Dec 31, 2017 | Dec 31, 2016 | Dec 31, 2015 |
|---|---|---|---|---|---|---|---|---|
| Germany Revenue | 3.21M | 5.42M | 6.53M | 7.6M | 9.01M | 11.22M | 14.7M | 13.79M |
| Germany Revenue Growth | -40.70% | -16.92% | -14.11% | -15.64% | -19.70% | -23.70% | +6.57% | n/a |
| Non-Us Revenue | 4.08M | 1.91M | 1.28M | 1.9M | 1.56M | 1.49M | 1.85M | 1.76M |
| Non-Us Revenue Growth | +114.22% | +49.14% | -32.74% | +21.56% | +4.69% | -19.47% | +5.22% | n/a |
| United States Revenue | 50.53M | 50.99M | 50.74M | 67.15M | 68.06M | 64.39M | 62.37M | 47.23M |
| United States Revenue Growth | -0.91% | +0.50% | -24.44% | -1.33% | +5.69% | +3.25% | +32.04% | n/a |
Operating Expense Breakdown
| Period Ending | Jun 30, 2023 | Mar 31, 2023 | Dec 31, 2022 | Sep 30, 2022 | Jun 30, 2022 | Mar 31, 2022 | Dec 31, 2021 | Sep 30, 2021 | Jun 30, 2021 | Mar 31, 2021 | Dec 31, 2020 | Sep 30, 2020 | Jun 30, 2020 | Mar 31, 2020 | Dec 31, 2019 | Sep 30, 2019 | Jun 30, 2019 | Mar 31, 2019 | Dec 31, 2018 | Sep 30, 2018 | Jun 30, 2018 | Mar 31, 2018 | Dec 31, 2017 | Sep 30, 2017 | Jun 30, 2017 | Mar 31, 2017 | Dec 31, 2016 | Sep 30, 2016 | Jun 30, 2016 | Mar 31, 2016 | Dec 31, 2015 | Sep 30, 2015 | Jun 30, 2015 | Mar 31, 2015 |
|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|
| Selling, General, and Administrative Revenue | 11.98M | 12.07M | 10.73M | 13.17M | 14.26M | 16M | 15.29M | 13.84M | 12.99M | 11.78M | 12.13M | 11.89M | 10.58M | 12.3M | 12.39M | 11.32M | 12.19M | 13.51M | 15.78M | 15.63M | 15.61M | 16.55M | 16.29M | 16.14M | 15.82M | 19.27M | 17.89M | 14.8M | 16.14M | 17.78M | 17.08M | 15.88M | 15.11M | 15.36M |
| Selling, General, and Administrative Revenue Growth | -0.77% | +12.55% | -18.54% | -7.61% | -10.90% | +4.66% | +10.43% | +6.53% | +10.31% | -2.86% | +1.99% | +12.41% | -14.01% | -0.77% | +9.52% | -7.12% | -9.80% | -14.39% | +0.93% | +0.15% | -5.68% | +1.61% | +0.90% | +2.05% | -17.93% | +7.71% | +20.88% | -8.25% | -9.26% | +4.09% | +7.57% | +5.08% | -1.60% | n/a |
| Research and Development Revenue | 2.16M | 2.46M | 3.23M | 3.68M | 3.96M | 4.48M | 4.05M | 3.55M | 3.65M | 3.54M | 3.35M | 2.87M | 2.74M | 2.99M | 3.06M | 3.16M | 3.33M | 2.91M | 3.46M | 3.87M | 4.85M | 4.69M | 4.16M | 4.08M | 4.33M | 4.56M | 4.13M | 4.1M | 3.98M | 4.4M | 4.78M | 3.88M | 4.32M | 4.02M |
| Research and Development Revenue Growth | -12.21% | -23.83% | -12.21% | -7.12% | -11.63% | +10.51% | +14.23% | -2.79% | +3.11% | +5.83% | +16.71% | +4.67% | -8.43% | -2.13% | -3.38% | -4.99% | +14.29% | -15.79% | -10.58% | -20.27% | +3.32% | +12.84% | +1.94% | -5.86% | -4.93% | +10.30% | +0.85% | +3.07% | -9.57% | -7.97% | +23.01% | -10.01% | +7.50% | n/a |
| Sales and Marketing Revenue | 4.06M | 5.05M | 6.52M | 5.56M | 6.56M | 6.67M | 7.05M | 6.43M | 6.3M | 5.11M | 6.23M | 5.75M | 4.1M | 6.56M | 7.28M | 6.15M | 6.9M | 8.18M | 9.68M | 9.05M | 9.81M | 10.41M | 9.86M | 8.74M | 9.38M | 10.82M | 10.02M | 9.3M | 10.65M | 11.49M | 10.68M | 10.22M | 9.76M | 9.58M |
| Sales and Marketing Revenue Growth | -19.56% | -22.52% | +17.21% | -15.24% | -1.55% | -5.50% | +9.62% | +2.06% | +23.29% | -17.88% | +8.18% | +40.30% | -37.50% | -9.89% | +18.37% | -10.79% | -15.69% | -15.50% | +6.95% | -7.71% | -5.78% | +5.63% | +12.76% | -6.76% | -13.32% | +7.91% | +7.76% | -12.65% | -7.30% | +7.53% | +4.47% | +4.79% | +1.87% | n/a |